Novo Nordisk reprimanded in the UK
Danish drugmaker Novo Nordisk has been reprimanded by British regulators for failing to disclose fees and expenses paid to healthcare professionals and healthcare organisations in Britain, amounting to about 7.8 million pounds between 2020 and 2022.
ENTRADAS POPULARES
UK sets new climate target for 2035
noviembre 13, 2024
Children go back to school after Valencia floods
noviembre 13, 2024
Researchers document huge decline in African elephants
noviembre 13, 2024
Mission: Impossible 8 title revealed
noviembre 13, 2024
TRANSMISIÓN EN VIVO